US Broker Ratings

AdaptHealth Corp. (AHCO): Investor Outlook Reveals 55% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO) stands as a significant player in the healthcare sector, specifically within the medical devices industry. Headquartered in Plymouth Meeting, Pennsylvania, and founded in 2012, the company..

Viridian Therapeutics (VRDN) Stock Analysis: A 160% Upside Potential in the Biotechnology Sector

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a notable player in the biotechnology sector, is capturing investor attention with its promising pipeline and a striking potential upside of 160.45%. With a market..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with 192.88% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine. This Singapore-based company operates at the cutting edge of healthcare,..

agilon health, inc. (AGL) Stock Analysis: A Closer Look at Its 97.84% Potential Upside

Investors seeking opportunities in the healthcare sector should pay close attention to agilon health, inc. (NYSE: AGL), a company that provides healthcare services for seniors through primary care physicians across..

Schrodinger, Inc. (SDGR) Stock Analysis: A 56% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR) stands as an intriguing player in the healthcare sector, specifically within the health information services industry. Headquartered in New York, the company is recognized for its..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating a 19.77% Potential Upside Amidst Innovative Advancements

10x Genomics, Inc. (NASDAQ: TXG) stands as a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Pleasanton, California, this life sciences technology company..

Janux Therapeutics (JANX) Stock Analysis: Exploring a Potential 267.66% Upside in the Biotechnology Sector

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning player in the biotechnology sector, has caught the eye of investors with its cutting-edge approach to cancer treatment. Headquartered in San Diego, California,..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A Healthcare Play with 28% Upside Potential

Pediatrix Medical Group, Inc. (NYSE: MD) stands at a unique intersection of healthcare services with its specialized focus on neonatal and maternal-fetal care. Founded in 1979 and based in Sunrise,..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 23.94% Potential Upside in the Healthcare Sector

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly in the medical care facilities industry. Headquartered in Atlanta, Georgia, Aveanna..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 141% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is making waves in the biotechnology sector with its focus on precision medicine oncology. Headquartered in South San Francisco, California, IDEAYA is dedicated to developing..

Integra LifeSciences Holdings (IART) Stock Analysis: Exploring a 38.77% Potential Upside in a Challenging Market

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands as a significant player in the healthcare sector, particularly within the specialized field of medical devices. Headquartered in Princeton, New Jersey, the company..

NovoCure Limited (NVCR) Stock Analysis: Exploring A 96% Potential Upside Despite Current Challenges

NovoCure Limited (NASDAQ: NVCR), a pioneering company in the healthcare sector, focuses on innovative medical devices aimed at treating solid tumor cancers. Based in Baar, Switzerland, NovoCure is renowned for..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Uncertain Waters with a 13.73% Upside Potential

Teladoc Health, Inc. (NYSE: TDOC), a prominent player in the healthcare sector, is a pioneer in virtual healthcare services. The company has carved a niche in providing comprehensive telehealth solutions..

National HealthCare Corporation (NHC): Revenue Growth and Dividend Insights for Investors

National HealthCare Corporation (NYSE: NHC), a prominent player in the healthcare sector, stands out with its impressive revenue growth and stable dividend yield amidst a challenging market environment. As the..

Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating a 16% Potential Upside and Market Challenges

Bausch Health Companies Inc. (NYSE: BHC) stands as a key player in the healthcare sector, specifically in the drug manufacturing industry focusing on specialty and generic products. With a market..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Revenue Growth and 22.92% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stands as a noteworthy player in the healthcare sector, specializing in the development, manufacturing, and marketing of both branded and generic pharmaceutical products. With its..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Unveiling a 187% Potential Upside with Promising Biotech Innovations

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology industry, is catching the attention of investors with its innovative approaches to treating severe inflammatory, allergic, and autoimmune diseases...

GeneDx Holdings Corp. (WGS) Stock Report: Riding High on 39.6% Revenue Growth in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) has emerged as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $2.27 billion, this..

Harrow, Inc. (HROW) Stock Analysis: Robust Analyst Ratings Signal 83.5% Potential Upside

For investors eyeing opportunities in the healthcare sector, Harrow, Inc. (NASDAQ: HROW) offers an intriguing proposition. Specializing in ophthalmic pharmaceutical products, Harrow has captured the attention of analysts with a..

CG Oncology, Inc. (CGON) Stock Analysis: A 135% Potential Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) an intriguing opportunity, bolstered by a remarkable potential upside of 135.13%. As a late-stage..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds